Indian Journal of Urology
SYMPOSIUM
Year
: 2007  |  Volume : 23  |  Issue : 1  |  Page : 43--50

Update in palliative management of hormone refractory cancer of prostate


Pratipal Singh, Aneesh Srivastava 
 Department of Urology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India

Correspondence Address:
Aneesh Srivastava
Department of Urology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow
India

Hormone refractory prostate cancer (HRPC) is an incurable disease and as in the pressure sensitive adhesive era the median survival of patients is increasing, these men increasingly develop symptomatic problems as a result of advanced local and or metastatic disease during their progression to death. Recently, it has been shown that it is possible to improve survival in this group of patients with use of chemotherapy which reinforces the need of better options in palliative care. We discus the various clinical problems (Part I) and treatment options of palliative care (Part II) and try to formulate an action plan in this review.


How to cite this article:
Singh P, Srivastava A. Update in palliative management of hormone refractory cancer of prostate.Indian J Urol 2007;23:43-50


How to cite this URL:
Singh P, Srivastava A. Update in palliative management of hormone refractory cancer of prostate. Indian J Urol [serial online] 2007 [cited 2020 Nov 30 ];23:43-50
Available from: https://www.indianjurol.com/article.asp?issn=0970-1591;year=2007;volume=23;issue=1;spage=43;epage=50;aulast=Singh;type=0